XOMA Royalty Corp. (XOMA)
26.09
+0.60
(+2.35%)
USD |
NASDAQ |
Dec 24, 12:59
26.09
0.00 (0.00%)
After-Hours: 13:59
XOMA Royalty SG&A Expense (TTM): 32.68M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rezolute, Inc. | 20.85M |
| Vistagen Therapeutics, Inc. | 17.01M |
| Zevra Therapeutics, Inc. | 73.39M |
| DiaMedica Therapeutics, Inc. | 9.218M |
| Gossamer Bio, Inc. | 36.12M |